Hildenbrand, Florian F.
Illi, Barbara
von Felten, Stefanie
Bachofner, Jacqueline
Gawinecka, Joanna
von Eckardstein, Arnold
Müllhaupt, Beat
Mertens, Joachim C.
Blümel, Sena
Funding for this research was provided by:
Universität Zürich (Walter and Gertrud Siegenthaler Fellowship)
Novartis Foundation (23A064)
Article History
Received: 5 June 2023
Accepted: 29 December 2023
First Online: 30 January 2024
Declarations
:
: All patients provided written informed consent for the inclusion into SCCS (KEK ZH number EK-695). The study protocol for the presented study was in accordance with the ethical guidelines of the Declaration of Helsinki and was approved by the ethics committee of the Canton of Zurich (BASEC number 2016 − 00341).
: Not applicable.
: ELISA kits for sST2 measurements were provided by Ruwag Diagnostics, Bettlach, Switzerland. The company was neither involved in data analyses nor in the preparation and review of the manuscript. No other conflicts of interest exist for any of the authors related to this manuscript.